Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/51194
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation
Author: van Leeuwen, M.
Grulich, A.
Webster, A.
McCredie, M.
Stewart, J.
McDonald, S.
Amin, J.
Kaldor, J.
Chapman, J.
Vajdic, C.
Citation: Blood, 2009; 114(3):630-637
Publisher: American Society of Hematology
Issue Date: 2009
ISSN: 0006-4971
1528-0020
Statement of
Responsibility: 
Marina T. van Leeuwen,Andrew E. Grulich, Angela C. Webster, Margaret R.E. McCredie, John H. Stewart, Stephen P. McDonald, Janaki Amin, John M. Kaldor, Jeremy R. Chapman, and Claire M. Vajdic
Abstract: Non-Hodgkin lymphoma (NHL) incidence is greatly increased after kidney transplantation. NHL risk was investigated in a nationwide cohort of 8164 kidney transplant recipients registered on the Australia and New Zealand Dialysis and Transplant Registry. NHL diagnoses were ascertained using linkage with national cancer registry records. Multivariate Poisson regression was used to compute incidence rate ratios (IRRs) with 95% confidence intervals (CIs) comparing risk by transplant function, and risk factors for early (< 2 years) and late (≥ 2 years) NHL during the first transplantation. NHL occurred in 133 patients. Incidence was strikingly lower after transplant failure and cessation of immunosuppression than during transplant function (IRR, 0.25; 95% CI, 0.08-0.80; P = .019). Early NHL (n = 27) was associated with Epstein-Barr virus (EBV) seronegativity at transplantation (IRR, 4.66; 95% CI, 2.10-10.36, P < .001) and receipt of T cell–depleting antibodies (IRR, 2.39; 95% CI, 1.08-5.30; P = .031). Late NHL (n = 79) was associated with increasing year of age (IRR, 1.02; 95% CI, 1.01-1.04; P = .006), increasing time since transplantation (P < .001), and current use of calcineurin inhibitors (IRR, 3.13; 95% CI, 1.53-6.39; P = .002). These findings support 2 mechanisms of lymphomagenesis, one predominantly of primary EBV infection in the context of intense immunosuppression, and another of dysregulated lymphoid proliferation in a prolonged immunosuppressed state.
Keywords: Humans
Epstein-Barr Virus Infections
Lymphoma, Non-Hodgkin
Immunosuppression
Lymphocyte Depletion
Kidney Transplantation
Registries
Incidence
Multivariate Analysis
Risk Factors
Retrospective Studies
Cohort Studies
Age Factors
Time Factors
Adult
Aged
Middle Aged
Female
Male
Young Adult
Rights: © 2009 by The American Society of Hematology
DOI: 10.1182/blood-2009-02-202507
Grant ID: http://purl.org/au-research/grants/nhmrc/510346
http://purl.org/au-research/grants/nhmrc/401131
Appears in Collections:Aurora harvest
Public Health publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.